Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 2Endocrine 2Sarcoma 1Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Esophageal Neoplasms 10Carcinoma, Hepatocellular 10Rectal Neoplasms 9Colorectal Neoplasms 8Stomach Neoplasms 7Pancreatic Neoplasms 7Colonic Neoplasms 7Lung Neoplasms 6Breast Neoplasms 6Urinary Bladder Neoplasms 4Cholangiocarcinoma 4Carcinoma, Transitional Cell 4Salivary Gland Neoplasms 3Ovarian Neoplasms 3Neuroendocrine Tumors 3Liver Neoplasms 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Anus Neoplasms 3Adenocarcinoma Of Esophagus 3Uterine Cervical Neoplasms 2Tongue Neoplasms 2Thyroid Neoplasms 2Testicular Neoplasms 2Sarcoma 2Oropharyngeal Neoplasms 2Nasopharyngeal Neoplasms 2Mouth Neoplasms 2Laryngeal Neoplasms 2

Interventions

Cisplatin 3Irinotecan 2tivozanib 1surufatinib 1sintilimab 1repotrectinib 1pralsetinib 1copper dotatate CU-64 1atezolizumab 1Topotecan 1Specimen Handling 1Nivolumab 1Neoadjuvant Therapy 1Melphalan 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Interferon-alpha 1Gemcitabine 1Fluorodeoxyglucose F18 1Everolimus 1Etoposide 1Copper 1Carboplatin 1Biopsy 1BAY 1895344 1Aromatherapy 164Cu-DOTATATE 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Neuroendocrine × Fluorodeoxyglucose F18 × Gastrointestinal × Clear all
NCT05709171 2023-11-22

Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms

Rigshospitalet, Denmark

Phase 2 Unknown
200 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡